Measurable Residual Disease Assessment in B-Lymphoblastic Leukemia Using 5- and 10-Color Flow Cytometry: An Institutional Experience

Key Points

• Improved recognition of low-level residual disease was achieved with 10-color flow cytometry, enhancing diagnosis.
• Five-color flow cytometry effectively facilitated measurable residual disease assessment in B-ALL cases.
• Observational analysis detailed an institutional experience utilizing flow cytometry for B-ALL management.
• These findings support integrating flow cytometry-based evaluations into routine post-induction assessments for better outcomes.